Pediatric Hemp-Derived Cannabinoid and Δ9-THC Exposures: A National Poison Data Study.
This study examines pediatric hemp-derived cannabinoid exposures, focusing on unintentional ingestion risks in children. It highlights increased toxicity compared to Δ9-THC. The findings emphasize the need for awareness and clinical vigilance.
Dr. Rand Paul Introduces the Bipartisan Hemp Safety Enforcement Act
The Hemp Safety Enforcement Act addresses regulatory oversight of hemp-derived products, focusing on Delta-8 THC safety. This legislation aims to establish clear federal standards to improve product quality and patient safety. Clinicians and patients…
New Jersey Hemp Product Restrictions Take Effect – Marijuana Moment
New Jersey hemp product restrictions are reshaping patient access to cannabinoid therapeutics. These regulations create compliance challenges for clinicians recommending hemp-derived products. Understanding new jersey hemp product restrictions is vital…
Ohio Judge Temporarily Pauses Hemp Product Ban For Two Businesses
An Ohio judge has issued a temporary hemp product ban pause for two businesses, creating a legal window for patient access. This temporary hemp product ban pause highlights ongoing regulatory uncertainty. Patients and clinicians must navigate these…
3 US Senators Propose State Opt-Out for Hemp Product Ban
The hemp product ban is facing new challenges as three US senators propose allowing states to opt out of federal restrictions. This change could create a patchwork of state regulations for intoxicating hemp products. Clinicians must be aware of these…
Texas Judge Temporarily Blocks State Ban on Smokable Hemp and THC Products – CBS News
Legal uncertainty hemp cannabinoids directly impact patient access to therapeutic products and create compliance challenges for clinicians. A Texas judge temporarily blocked the state's ban on smokable hemp and certain THC products, preserving access.…
Dallas Hemp Shops React to Texas Hemp Regulations Impact
Texas hemp regulations impact patient access to delta-8 THC products used for symptom management. Regulatory uncertainty creates challenges for patients relying on these cannabinoids. Dallas hemp shops react to the stalled Texas THC ban and its effects…
Hemp Leaders Challenge Texas Intoxicating Smokables Ban
The texas intoxicating smokables ban has prompted hemp leaders to file a lawsuit challenging the new restrictions. This ban affects delta-8 THC products used by patients for symptom management. The legal challenge highlights ongoing regulatory…
Missouri Bill Pulling Hemp-Derived Cannabinoids Off Shelves in November
Missouri hemp derived cannabinoids regulation will remove intoxicating hemp products from retail shelves starting November 2024. This change affects delta-8, delta-10, and similar cannabinoids. Clinicians should counsel patients on this regulatory shift…
Hemp Businesses in Massachusetts Face Uncertain Future Amid Federal Ban
Federal hemp regulatory uncertainty is creating challenges for Massachusetts hemp businesses and patient access to cannabinoid therapies. The looming federal ban on intoxicating hemp compounds complicates clinical prescribing and treatment continuity.…
